Literature DB >> 12407571

National Institutes of Health Consensus Development Conference: management of hepatitis C: 2002.

Leonard B Seeff1, Jay H Hoofnagle.   

Abstract

Mesh：

Year:  2002        PMID： 12407571     DOI： 10.1053/jhep.2002.36992

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  75 in total

1.  Influence of body mass index on outcome of pediatric chronic hepatitis C virus infection.

Authors:  Aymin Delgado-Borrego; David Healey; Betania Negre; Marielle Christofi; Sabina Sabharwal; David A Ludwig; Raymond T Chung; Maureen M Jonas
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-08       Impact factor: 2.839

2.  Current strategies for managing providers infected with bloodborne pathogens.

Authors:  Sarah Turkel; David K Henderson
Journal:  Infect Control Hosp Epidemiol       Date:  2011-05       Impact factor: 3.254

Review 3.  Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: a review and analysis of 36 cases.

Authors:  M Afshar; A D Martinez; R L Gallo; T R Hata
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-06-01       Impact factor: 6.166

4.  Hepatitis C among clients of health care for the homeless primary care clinics.

Authors:  Aaron J Strehlow; Marjorie J Robertson; Suzanne Zerger; Catherine Rongey; Lisa Arangua; Ed Farrell; Adele O'Sullivan; Lillian Gelberg
Journal:  J Health Care Poor Underserved       Date:  2012-05

5.  NIM811, a cyclophilin inhibitor, exhibits potent in vitro activity against hepatitis C virus alone or in combination with alpha interferon.

Authors:  Sue Ma; Joanna E Boerner; ChoiLai TiongYip; Beat Weidmann; Neil S Ryder; Michael P Cooreman; Kai Lin
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

6.  Barriers to accessing care in patients with chronic hepatitis C: the impact of depression.

Authors:  D M Evon; K M Simpson; D Esserman; A Verma; S Smith; M W Fried
Journal:  Aliment Pharmacol Ther       Date:  2010-09-17       Impact factor: 8.171

7.  Immediate virological response predicts the success of short-term peg-interferon monotherapy for chronic hepatitis C.

Authors:  Masayoshi Yada; Akihide Masumoto; Naoki Yamashita; Kenta Motomura; Toshimasa Koyanagi; Shigeru Sakamoto
Journal:  World J Gastroenterol       Date:  2010-03-28       Impact factor: 5.742

8.  Interferon alfacon-1 and ribavirin versus interferon alpha-2b and ribavirin in the treatment of chronic hepatitis C.

Authors:  Maria H Sjogren; Robert Sjogren; Kent Holtzmuller; Bradley Winston; Betty Butterfield; Stanley Drake; Amber Watts; Robin Howard; Milton Smith
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

9.  Pegylated interferon and ribavirin treatment for hepatitis C virus infection.

Authors:  Emilio Palumbo
Journal:  Ther Adv Chronic Dis       Date:  2011-01       Impact factor: 5.091

10.  Process of care for hepatitis C infection is linked to treatment outcome and virologic response.

Authors:  Fasiha Kanwal; Tuyen Hoang; Timothy Chrusciel; Jennifer R Kramer; Hashem B El-Serag; Jason A Dominitz; Steven M Asch
Journal:  Clin Gastroenterol Hepatol       Date:  2012-07-25       Impact factor: 11.382
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.